MedservRegis Plc

Report Publication Announcement • Jun 16, 2022

COMPANY ANNOUNCEMENT

MEDSERVREGIS P.L.C. (THE "COMPANY")

Approval of Annual Financial Statements

Date of Announcement	16 June 2022
Reference	263/2022
Listing Rule	LR 5.16, 5.16.21, 15.16.24, 5.56

Quote

Reference is made to company announcement 262/2022 pursuant to which the Company announced that the publication of the consolidated financial statements of the Company for the year ended 31 December 2021 will take place on the 15 June 2022.

Despite the Company's best efforts, the Company was unable to publish the said financial statements on the 15th June 2022 due to an external technical IT infrastructural failure arising outside the control of the Company. Nonetheless, the matter has been rectified and in terms of Rule 5.16.21 the Company is hereby announcing, following approval by the Board of Directors, the publication of the audit consolidated financial statements of the Company for the year ended 31 December 2021.

The total revenue generated for the year amounted to € 29,924,554 (2020: €11,286,556) as against a forecast of €44,595,000. Adjusted Earnings before interest, tax, depreciation and amortization (EBITDA) amounted to €5,304,677 (2020: negative €4,012,109) as against a forecast of €10,692,000. Forecast results are those projected in the financial analysis summary published on the 28th June 2021.

The results for the year differ significantly from the forecast published in the financial analysis summary. The main reason for this difference is that the forecast for financial year 2021 comprises the twelve-month results of Medserv plc and the six-month results of Regis Holdings Limited. The audited consolidated financial statements for the financial year ended 31 December 2021 account for the share for share exchange transaction as a reverse acquisition. As a result of the reverse acquisition the Consolidated Statement of Profit or Loss and Other Comprehensive Income for the year ended 31 December 2021 includes the financial results of Regis group of companies for the entire year and the financial results of the formerly Medserv group of companies from 1 July 2021 until year-ended 31 December 2021.

The Board of Directors resolved that the Annual Report 2021 be submitted for the approval of the shareholders at the forthcoming Annual General Meeting, to be held on 28th July 2022.

The Board of Directors has authorised the publication of the Annual Report 2021, which is available for viewing on the Company's website at http://www.medservenergy.com/medservregis-plc-financial-statements

Attached to this Company Announcement is a Directors' Declaration on the ESEF Annual Financial Reports.

Unquote

Laragh Cassar Company Secretary

DIRECTORS' DECLARATION ON ESEF ANNUAL REPORT

We, Anthony S. Diacono and David S. O'Connor, in our capacity as Directors of MedservRegis p.l.c (Company registration number: C28847), hereby certify:

• i. That the Annual Report for the year ended 31 December 2021 has been approved by the Board of Directors of the Company and is hereby being made available to the public.
• ii. That the Annual Report has been prepared in terms of the applicable rules and regulations, including the Commission Delegated Regulation on the European Single Electronic Format ("ESEF")1 and the Capital Markets Rules2.
• iii. That the Audit Report on the ESEF Annual Report is an exact copy of the original signed by the auditor and that no alterations have been made to the audited elements of the Annual Report including the annual financial statements.
• iv. That the Annual Report shall serve as the official document for the purposes of the Capital Markets Rules and, where the issuer is registered in Malta, the Companies Act (Chapter 386 of the Laws of Malta).

Anthony S. Diacono Chairman

(David S. O'Connor Director & CEO

Date: 16 June 2022

¹ Commission Delegated Regulation 2019/815 on the European Single Electronic Format, as may be from time to time.

² Capital Markets Rules as issued by the Malta Financial Services Authority (MFSA).